Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 18, 2015 17:51 ET | Source: Genclis SAS

D-Eye Srl names Galileo Diagnostics, commercial branch of Genclis SA, international distributor for Veterinary Market

NANCY, France and PADOVA, Italy and PASADENA, Calif., March 18, 2015 (GLOBE NEWSWIRE) -- D-Eye, a leading developer of advanced devices for mass health screenings and data analytics, and Genclis, a...
January 09, 2015 01:35 ET | Source: Genclis SAS

Genclis selected to present its diagnostic technology Severidia(R) at the St. Gallen International Breast Cancer Conference

NANCY, France, Jan. 9, 2015 (GLOBE NEWSWIRE) -- Genclis, a molecular diagnostic company in the fields of allergy and cancer, today announced that its communication on "using next generation sequencing...
November 25, 2014 01:37 ET | Source: Genclis SAS

Genclis SAS : Confirms Potential of its Severidia(R) Test on 47 TNBC patients

100% of patients classified with Severidia® in the "good outcome" subgroup were alive after 2,500 days Improved p value (p < 10-5) NANCY, France, Nov. 25, 2014 (GLOBE NEWSWIRE)...
November 20, 2014 15:24 ET | Source: Genclis SAS

Genclis SAS Coordinate a Roundtable in a Molecular Allergology Seminar

NANCY, France, Nov. 20, 2014 (GLOBE NEWSWIRE) -- Genclis, a molecular diagnostic company in the fields of allergy and cancer, will attend the 2nd French Molecular Allergology Seminar in Paris on...
October 29, 2014 12:04 ET | Source: Genclis SAS

Genclis SAS Releases First Data for Severidia(r) Molecular Diagnostic in Triple-Negative Breast Cancer

NANCY, France, Oct. 29, 2014 (GLOBE NEWSWIRE) -- Genclis, a molecular diagnostic company in the fields of allergy and cancer, announced today the presentation of the first clinical data for its...
October 13, 2014 10:43 ET | Source: Genclis SAS

Genclis SAS appoints Mr. Stephane Boissel as CEO

NANCY, France, Oct. 13, 2014 (GLOBE NEWSWIRE) -- Genclis, an innovative diagnostic company in the fields of allergy and cancer, announced today the appointment of Mr. Stéphane Boissel as CEO. His...